NRx Pharmaceuticals, Inc. (NRXP) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Get detailed NRx Pharmaceuticals, Inc. (NRXP) stock forecast for 2025, monthly, along with long-term NRXP price prediction from 2025 to 2050. Look at historical stock performance, analyst recommendations (Buy, Sell, or Hold), and the latest NRx Pharmaceuticals, Inc. headlines.
1 Month Prediction
$5.37 [18.84%]
3 Month Prediction
$3.94 [-12.84%]
6 Month Prediction
$3.06 [-32.40%]
1 Year Prediction
$1.62 [-64.23%]
3 Year Prediction
$1.00 [-77.88%]
5 Year Prediction
$1.00 [-77.88%]
About NRx Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in Wilmington, Delaware. Founded in 2015, the company develops therapeutics targeting central nervous system disorders, including suicidal depression, post-traumatic stress disorder (PTSD), and chronic pain.
Its lead product candidate is NRX-101, which is an oral, fixed-dose combination of D-cycloserine and lurasidone, designed to treat suicidal treatment-resistant bipolar depression.
NRx Pharmaceuticals, Inc. (NRXP) Historical Performance
Change
Since inception, NRXP has decreased by 95.35%. In the last 5 years, NRXP has fallen from $106.50 to $4.52, a massive -95.76% decrease since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $587.40 and a low of $1.31.
52 Week Range
$1.1
$7.33
The current price $4.52 is not near the 52-week extremes, which means that the stock is neither overbought nor underbought.
NRXP Stock Price History
Based on NRXP stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the NRXP stock has fallen from $105.0 - $244.0 to $4.52 - $4.52, which is down -95.69%. Currently, the stock follows downward trend.
Here, we have calculated stock range of NRXP, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $105.0 - $244.0 | $119.78 | 14.25 | 1 Year Change |
| 2021 | $47.8 - $587.4 | $222.28 | 112.01 | 2 Year Change |
| 2022 | $5.59 - $29.9 | $13.89 | -86.75 | 3 Year Change |
| 2023 | $2.6 - $11.7 | $5.57 | -94.69 | 4 Year Change |
| 2024 | $1.31 - $4.72 | $2.63 | -97.49 | 5 Year Change |
| 2025 | $4.52 - $4.52 | $4.52 | -95.69 | 6 Year Change |
NRXP Price Performance
6-Month Performance
NRXP stock jumped by 141.74% in the last six months.
1-Year Performance
The stock has trended upwards by 25.92% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 84.88%.
5-Year Performance
In the last 5 years, the stock has gone down by 95.76%.
According to NRx Pharmaceuticals, Inc.'s historical data, below graph gives us the exact picture of how the NRXP stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 1 year and a decline in 4 years.
2020
130.19% ↑
2021
80.41% ↓
2022
76.78% ↓
2023
58.56% ↓
2024
52.17% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
NRx Pharmaceuticals, Inc. (NRXP) Financials & Stock Analysis
Market Capitalization
NRx Pharmaceuticals, Inc. has a market capitalization of $54.67M, which places NRXP in the micro-cap category.
Fundamental Analysis
EPS: $-0.15 (Q3), $-4.00 (1Y)
EPS decreased 80.00% since last quarter, and decreased 33.33% since last year.
Net Income: $-1.62 M (Q3), $-30.15 M (1Y)
Net Income decreased 79.45% since last quarter, and decreased 24.16% since last year.
Free Cash Flow: $-2.31 M (Q3), $-21.66 M (1Y)
Free Cash Flow decreased N/A since last quarter, and decreased N/A since last year.
Below, we have listed 12 key indicators for Fundamental analysis for NRXP stock. These indicators help you understand NRx Pharmaceuticals, Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for NRXP stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $1.84 |
| SMA50 | $1.50 |
| SMA200 | $2.39 |
| RSI | 87.06 |
| Beta | 1.27 |
SMA20 < Current Price
This signals NRXP stock is in short-term bullish momentum.
SMA50 < Current Price
This signals NRXP stock is in mid-term bullish momentum.
SMA200 < Current Price
This signals NRXP stock is in long-term bullish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for NRXP stock is Bullish. Out of all indicators, 5 indicates bullish signals, 4 signals bearish trends and 0 gives neutral trends. The NRXP stock forecast was last updated on 07 January, 2025.
NRx Pharmaceuticals, Inc. (NRXP) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to fall to $2.71 by the end of 2025, and can reach around $5.20 to $1.69 in 2026. And, the long-term forecast suggests that the stock may further drop to $1.24 - $1.31 in 2028, and $1.27 - $-0.08 by 2031. So, the NRXP stock shows a strong downward trend in the next several years.
Short-term NRXP Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-02 | $5.37 | 18.79% |
| 2025-03 | $6.28 | 38.92% |
| 2025-04 | $3.94 | -12.84% |
| 2025-05 | $5.01 | 10.83% |
| 2025-06 | $3.48 | -23.02% |
| 2025-07 | $3.06 | -32.31% |
| 2025-08 | $1.40 | -69.03% |
| 2025-09 | $1.05 | -76.77% |
| 2025-10 | $1.56 | -65.49% |
| 2025-11 | $1.67 | -63.06% |
| 2025-12 | $2.71 | -40.05% |
In 2025, the NRXP stock price is expected to fluctuate between $1.05 and $6.28. According to the monthly forecast, the stock could drop to $2.71 by December 2024. If compared to the NRXP's current price, the stock could lose -40.05% by the end of this year.
Long-term NRXP Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $5.20 | $0.99 | $1.69 | -62.61% |
| 2027 | $0.19 | $1.40 | $1.25 | -72.35% |
| 2028 | $1.24 | $1.26 | $1.31 | -71.02% |
| 2029 | $1.66 | $1.25 | $0.73 | -83.85% |
| 2030 | $0.81 | $1.29 | $0.88 | -80.53% |
| 2031 | $1.27 | $0.59 | $-0.08 | -101.77% |
| 2032 | $1.50 | $0.75 | $1.12 | -75.22% |
| 2033 | $1.11 | $0.87 | $1.13 | -75.0% |
| 2034 | $0.77 | $0.76 | $1.73 | -61.73% |
| 2035 | $0.99 | $1.62 | $0.93 | -79.43% |
| 2036 | $0.65 | $1.26 | $1.06 | -76.55% |
| 2037 | $1.10 | $0.27 | $1.74 | -61.51% |
| 2038 | $1.08 | $0.66 | $0.74 | -83.63% |
| 2039 | $1.32 | $1.33 | $0.75 | -83.41% |
| 2040 | $0.79 | $0.18 | $0.73 | -83.85% |
| 2041 | $1.03 | $0.82 | $1.03 | -77.21% |
| 2042 | $0.66 | $0.80 | $0.53 | -88.28% |
| 2043 | $0.85 | $0.54 | $1.22 | -73.01% |
| 2044 | $1.14 | $0.78 | $0.90 | -80.09% |
| 2045 | $0.46 | $0.82 | $0.95 | -78.98% |
| 2046 | $0.88 | $0.91 | $0.92 | -79.65% |
| 2047 | $1.34 | $0.57 | $1.35 | -70.14% |
| 2048 | $1.76 | $0.37 | $1.00 | -77.88% |
| 2049 | $1.07 | $1.20 | $1.83 | -59.52% |
| 2050 | $1.53 | $1.21 | $1.28 | -71.68% |
| 2051 | $1.17 | $0.82 | $1.10 | -75.67% |
NRx Pharmaceuticals, Inc. (NRXP) Stock Price Prediction & Forecast 2025
At the start of 2025, the NRXP stock was at $4.52. Today, it is trading at $4.52, which is 0.00% increase from price at the beginning of the year. By the end of this year, you can expect the stock to fall to $2.71 by December 2025 with a -40.05% change.
NRx Pharmaceuticals, Inc. (NRXP) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant depreciation in the NRXP stock. During this period, the NRXP's price is forecasted to shift from $5.20 to $0.88, which is -83.08% loss.
In 2026, the stock would possibly open at $5.20, descends to $0.99 by mid-year, and wraps up at $1.69, reflecting a decrease from today's price. Further moving to 2030, the stock can kick off the year at $0.81, drop to $1.29 by mid-year, and finish at $0.88, which is -80.58% change from current price.
NRx Pharmaceuticals, Inc. (NRXP) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $1.27 to $0.73, which is down -101.70%
In 2031, we can expect NRXP to fluctuate between $-0.08 and $1.27, a shift indicating a -101.70% loss by year-end compared to current price. And Until 2040, NRXP can likely vary from $0.73 to $0.79. By the end of 2040, the stock could record a -83.96% fall from today's stock price.
NRx Pharmaceuticals, Inc. (NRXP) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the NRXP stock can see an an upturn from $1.03 to $1.28 in this period. In 2041, the stock can experience a low of $0.82 by mid-year, closing the year at $1.03. This results in a -81.87% decrease from today.
Moving towards the end of 2050, NRXP is projected to open the year at $1.53. The stock may dip to $1.21 during mid-year and finish the year at $1.28. Compared to the stock's current price, this translates to an overall loss of -71.72% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
NRXP Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| HOTH | Hoth Therapeutics, Inc. | - | $2.47 | 0.00% ▼ | -23.28 ▼ |
| SANA | Sana Biotechnology, Inc. | - | $4.49 | -0.11% ▼ | $225.59 ▲ |
| OTLK | Outlook Therapeutics, Inc. | - | $1.47 | -28.29% ▼ | $648.24 ▲ |
| CABA | Cabaletta Bio, Inc. | - | $2.34 | -38.74% ▼ | $769.02 ▲ |
| PHIO | Phio Pharmaceuticals Corp. | - | $1.76 | -35.29% ▼ | -43.18 ▼ |
Last updated Jan 07 at 8:59 PM
NRXP : Buy, Sell Or Hold?
Analyst Ratings
Based on 1 analysts, 0 rated as a strong buy, 1 recommended a buy, 0 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.Three months ago, out of 2 analysts, 0 analysts gave a strong buy rating, 2 a buy rating, 0 a hold rating, 0 advised selling, and 0 suggested a strong sell.So, according to analyst ratings, the recommendation for NRXP stock is Buy.
Expert Analysis
According to NRXP short-term and long-term forecast, NRx Pharmaceuticals, Inc. shares are projected to go down by 71.68%, and reach a value of $1.28 per share by 2050.
As per technical analysis, indicators show a Bullish sentiment, while Fear & Greed Index stands at 57.142857142857146, which signals Greed. Also, NRXP has recorded 9/30 green days, which reflects a 45.0% positivity rate with a price volatility of 0.14%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that NRXP stock is undervalued. So, Based on NRXP prediction and analysis, it may be the best time to hold NRXP stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "NRXP” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.